If you or someone you know has LBD:
Did you know? Both healthy individuals and people with LBD can participate in research. People of all races and ethnicities are urgently needed!
If you are a Researcher:
LBDA may be able to help more people learn about your study! To initiate a request, please download, complete and return this form to LBDA.
The following research studies and clinical trials are actively recruiting people with dementia with Lewy bodies (DLB) or Parkinson’s disease dementia (PDD). Find a study near you and contact the study coordinator to see if you may qualify.
For more information on clinical trials, visit www.clinicaltrials.gov.
The purpose of this study (AscenD-LB) is to understand if neflamapimod has an effect on cognitive function (attention, memory) in those with dementia with Lewy bodies (DLB).
The purpose of this study is to understand if E2027 has any effect on slowing cognitive decline and visual hallucinations for people with DLB.
The purpose of this study to collect clinical information, brain imaging scans, and biological samples from people with dementia with Lewy bodies. The information and samples collected will be analyzed for discovery of new biomarkers (biological signs) of DLB. People with mild cognitive impairment associated with Lewy body dementia are also needed.
The aim of this study is to develop better biomarkers for diagnosis and treatment of Lewy body disorders.
The aim of this study is to develop a test that can detect a problem in the body’s ability to regulate a type of fat (also called a lipid) in nerve cell membranes. This specific lipid is called a sphingolipid. A test for a ‘bad sphingolipid’ would be helpful in developing treatments for cognitive symptoms of LBD.
The aim of this study is to determine what features can help identify different sub-types of LBD. This includes studying the symptoms and using brain imaging to detect whether one or more disease process is unfolding in the brain.